Joint bioequivalence testing to be permitted next year

The Korea Food and Drug Administration said that the joint bioequivalence testing, which has been implemented on a limited basis, would be fully utilized by those companies which may cope with the new guideline to be formulated by a KFDA’s consultative body.

The drug agency hinted that the future joint bioequivalence testing system will be tightly controlled so as to prevent improper practic...